Letermovir Reduces CMV Infection, Improves Survival After Stem Cell Transplantation – Oncology Nurse Advisor
|
Letermovir Reduces CMV Infection, Improves Survival After Stem Cell Transplantation
Oncology Nurse Advisor Clinical trial results presented at the American Society for Blood and Marrow Transplantation (ASBMT) 2017 BMT Tandem Meetings described the use of a novel agent, letermovir, to prevent cytomegalovirus (CMV) in patients undergoing hematopoietic stem … |
